The G-protein-coupled receptor accessory protein MRAP2 is implicated in energy control in
rodents, notably via the melanocortin-4 receptor 1 . Although some MRAP2 mutations have …

Background Rare biallelic pathogenic mutations in PCSK1 (encoding proprotein convertase
subtilisin/kexin type 1 [PC1/3]) cause early-onset obesity associated with various …

The glucagon-like peptide 1 receptor (GLP1R) is a major drug target with several agonists
being prescribed in individuals with type 2 diabetes and obesity 1 , 2 . The impact of genetic …

Purpose Recessive deficiency of proopiomelanocortin (POMC) causes childhood-onset severe
obesity. Cases can now benefit from the melanocortin 4 receptor agonist setmelanotide. …

We previously demonstrated that 50% of children with obesity from consanguineous families
from Pakistan carry pathogenic variants in known monogenic obesity genes. Here, we have …

Objective Human functional genomics has proven powerful in discovering drug targets for
common metabolic disorders. Through this approach, we investigated the involvement of the …

Recent advances in genetic analysis have significantly helped in progressively attenuating
the heritability gap of obesity and have brought into focus monogenic variants that disrupt the …

Human induced pluripotent stem cells (hiPSCs) have the potential to be differentiated into
any cell type, making them a relevant tool for therapeutic purposes such as cell-based …

Objective Heterozygous pathogenic or likely pathogenic (P/LP) PDX1 variants cause
monogenic diabetes. We comprehensively examined the phenotypes of carriers of P/LP PDX1 …

Monogenic forms of obesity have been identified in ≤10% of severely obese European
patients. However, the overall spectrum of deleterious variants (point mutations and structural …